HTLV-I/II Confirmation Panel
| Also Known as (Alias) | Anti-HTLV-I/II Confirmatory |
| Indications | Confirmatory testing performed due to a reactive PRISM or Avioq-HTLV-I/II result. |
| Method | MP Diagnostics HTLV Blot 2.4 Western Blot Assay |
| Test Information | Assay is a qualitative immunoassay intended for confirming the presence of and differentiating antibodies to Human T-Lymphotropic Virus Type I and/or Human T-Lymphotropic Virus Type II in human serum or plasma with repeatedly reactive results by an FDA licensed HTLV-I/-II donor screening test. |
| Sample Requirements | Serum or Plasma (EDTA, heparin, sodium citrate, PPT, potassium oxalate or ACD) |
| Requested Volume | 6 mL |
| Minimum Volume or Pediatric volume | 1 mL |
| Shipping Information | Samples are acceptable at 2-8°C for 7 days; samples may be frozen at -20 °C |
| Requisition Form | Donor Testing RFT |
| Transaction Code | 3076-03 |
| CPT Codes | 86689 |
| Test Schedule | Every 2-3 weeks |
| Turn around Time (analytic time) | Varied, depending on batch size |
| Report/ Results | Seronegative, HTLV-I Seropositive, HTLV-II Seropositive, HTLV-I/II Seropositive, Indeterminate, Unreadable |
